BRAND REFERENCE
Semaglutide in South Africa — Ozempic®, Wegovy® and Rybelsus® Explained
One molecule, three brand names, two routes of administration. If you searched "semaglutide", this is the map — and a plain statement of what we do and do not supply.
WHAT WE DO NOT SUPPLY
We do not sell Ozempic®, Wegovy®, Rybelsus® or semaglutide in any form, and we are not a pharmacy. Our tirzepatide, retatrutide and eloralintide are research compounds for laboratory use only — not medicines, and not for human or veterinary use.
LIVING WATER LABS · RESEARCH-GRADE
Research-grade GLP compounds from LWL
Live price and stock. Lyophilised research vials, Janoshik HPLC purity certificates, dispatched from Johannesburg. For laboratory research use only.
Semaglutide is a single-receptor GLP-1 agonist. The research compounds LWL supplies sit further along the same pharmacology: tirzepatide adds GIP, retatrutide adds GIP and glucagon, and eloralintide targets the amylin receptor. Research-grade vials, for laboratory research.
Retatrutide 30mg
GLP-1 / GIP / glucagon receptor triple agonist
VIEW RESEARCH COMPOUND →
Retatrutide 60mg
GLP-1 / GIP / glucagon receptor triple agonist
VIEW RESEARCH COMPOUND →
Tirzepatide 30mg
GIP / GLP-1 receptor dual agonist
VIEW RESEARCH COMPOUND →
Tirzepatide 60mg
GIP / GLP-1 receptor dual agonist
VIEW RESEARCH COMPOUND →
Eloralintide
Selective amylin receptor agonist
VIEW RESEARCH COMPOUND →
Retatrutide certificate summary →Tirzepatide certificate summary →
Semaglutide is a GLP-1 receptor agonist developed by Novo Nordisk. It reaches the market under three brand names: Ozempic® and Wegovy® are once-weekly injectable pens at different strengths for different approved uses, and Rybelsus® is a once-daily tablet — one of the few oral peptide medicines, made possible by an absorption enhancer co-formulated with the peptide.
All three are registered prescription medicines, obtained through a healthcare provider and a licensed pharmacy. "Semaglutide" sold online outside that route — as a vial, a "compounded" preparation or a pen with an unfamiliar label — is not any of those brands, whatever the listing says.
We do not stock semaglutide in any form. The incretin compounds we hold are newer molecules studied in the same research field: tirzepatide (a GIP/GLP-1 dual agonist), retatrutide (a GLP-1/GIP/glucagon triple agonist) and eloralintide (an amylin receptor agonist), each supplied as a lyophilised research vial for laboratory use with Janoshik HPLC purity documentation.
Side by side
Ozempic®
Semaglutide · once-weekly injectable pen (Novo Nordisk)
Not stocked
Wegovy®
Semaglutide · once-weekly injectable pen, higher strengths (Novo Nordisk)
Not stocked
Rybelsus®
Semaglutide · once-daily oral tablet (Novo Nordisk)
Not stocked
What we hold
—
Tirzepatide, retatrutide and eloralintide research vials
LWL research GLP compounds compared
Receptor pharmacology, vial size and price per milligram — live. Pre-order prices include the 10% pre-order saving. Research use only.
| Compound | Receptor targets | Vial | Price | Per mg | Status |
|---|---|---|---|---|---|
| Retatrutide 30mgLY3437943 | GLP-1 / GIP / glucagon receptor triple agonist | 30 mg | R1,574 | R52.5/mg | PRE-ORDER · SHIPS 15 OCT · 10% OFF |
| Retatrutide 60mgLY3437943 | GLP-1 / GIP / glucagon receptor triple agonist | 60 mg | R3,399 | R56.6/mg | IN STOCK · SAME-DAY DISPATCH |
| Tirzepatide 30mgLY3298176 | GIP / GLP-1 receptor dual agonist | 30 mg | R1,259 | R42.0/mg | PRE-ORDER · SHIPS 15 OCT · 10% OFF |
| Tirzepatide 60mgLY3298176 | GIP / GLP-1 receptor dual agonist | 60 mg | R2,429 | R40.5/mg | PRE-ORDER · SHIPS 15 OCT · 10% OFF |
| EloralintideLY3841136 | Selective amylin receptor agonist | 15 mg | R2,699 | R180/mg | PRE-ORDER · SHIPS 15 OCT · 10% OFF |
Also searched as
These are the short forms, spellings and code designations people use for the same thing. They are listed so the terminology is unambiguous, not because any of them names a different product.
Questions
Do you sell semaglutide?
No. We do not stock semaglutide in any form — not the branded medicines and not as a research vial. The incretin research compounds we hold are tirzepatide, retatrutide and eloralintide.
What is the difference between Ozempic® and Wegovy®?
Both are Novo Nordisk pens containing semaglutide, at different strengths and for different approved uses. Rybelsus® is the oral tablet form. Only a healthcare provider can advise on any of them.
Is tirzepatide a type of semaglutide?
No. They are different molecules. Semaglutide acts on the GLP-1 receptor; tirzepatide acts on both the GIP and GLP-1 receptors. Our tirzepatide is a research compound for laboratory use, not a medicine.
What is "compounded semaglutide"?
A preparation made up by a compounding pharmacy rather than the manufacturer. It is not Ozempic® or Wegovy®, and quality depends entirely on who made it. Our page on compounded GLP-1 preparations covers how to tell what you are being offered.
CONTINUE TO THE RESEARCH COMPOUNDS
Read next
Every compound we supply is sold strictly for laboratory research purposes only. Not for human or veterinary use, and not a medicine. Nothing on this page is medical advice, a dosing instruction or a claim of any outcome.
Ozempic®, Wegovy® and Rybelsus® are registered trademarks of Novo Nordisk A/S. Living Water Labs is not affiliated with, endorsed by or connected to Novo Nordisk, and does not supply any of these medicines. The names are used here only to identify what they are.